1. 1 Stein H, Poppema S, Weiss LM, Anagnostopoulos I, Benharroch D, et al.: Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, et al. (eds): WHO Classification of Tumors, Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, International Agency for Research on Cancer (IARC), pp.321-334, 2008
2. 2 Bräuninger A, Wacker HH, Rajewsky K, Küppers R, Hansmann ML: Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma. Cancer Res. 63:1644-1651, 2003
3. 3 Anagnostopoulos I, Hansmann ML, Franssila K, Harris M, Harris NL, et al.: European Task Force on Lymphoma project on lymphocyte predominance Hodgkin disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin disease with a nodular growth pattern and abundant lymphocytes. Blood. 96:1889-1899, 2000
4. 5 Nam-Cha SH, Montes-Moreno S, Salcedo MT, Sanjuan J, Garcia JF, et al.: Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers. Mod Pathol. 22:1006-1015, 2009
5. 6 García-Cosío M, Santón A, Martín P, Camarasa N, Montalbán C, et al.: Analysis of transcription factor OCT.1, OCT.2 and BOB.1 expression using tissue arrays in classical Hodgkin's lymphoma. Mod Pathol 17:1531-1538, 2004